ALS Limited
ALS Limited (CPBLF) Financial Performance & Income Statement Overview
Explore the financials of ALS Limited (CPBLF), including yearly and quarterly data on income, cash flow, and balance sheets.
ALS Limited (CPBLF) Income Statement & Financial Overview
Explore comprehensive income reports for ALS Limited CPBLF, broken down by year and quarter.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $1.46B | $1.24B | $1.22B | $1.08B |
| Cost of Revenue | $1.12B | $781.40M | $990.70M | $857.30M |
| Gross Profit | $348.10M | $457.70M | $231.80M | $227.70M |
| Gross Profit Ratio | $0.24 | $0.37 | $0.19 | $0.21 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $137.20M | $0.00 | $66.60M |
| Operating Expenses | $0.00 | $137.20M | $105.20M | $120.30M |
| Total Costs & Expenses | $1.12B | $918.60M | $990.70M | $857.30M |
| Interest Income | $0.00 | $5.50M | $5.00M | $3.40M |
| Interest Expense | $0.00 | $35.50M | $28.70M | $27.10M |
| Depreciation & Amortization | $67.90M | $49.60M | $86.70M | $76.70M |
| EBITDA | $303.00M | $282.90M | $318.50M | $142.85M |
| EBITDA Ratio | $0.21 | $0.23 | $0.26 | $0.28 |
| Operating Income | $348.10M | $320.50M | $231.80M | $227.70M |
| Operating Income Ratio | $0.24 | $0.26 | $0.19 | $0.21 |
| Other Income/Expenses (Net) | -$169.20M | -$389.60M | -$42.10M | -$136.40M |
| Income Before Tax | $178.90M | -$69.10M | $189.70M | $181.90M |
| Income Before Tax Ratio | $0.12 | -$0.06 | $0.16 | $0.17 |
| Income Tax Expense | $51.20M | $49.80M | $56.60M | $50.50M |
| Net Income | $126.80M | -$120.60M | $133.50M | $131.50M |
| Net Income Ratio | $0.09 | -$0.10 | $0.11 | $0.12 |
| EPS | $0.26 | -$0.25 | $0.28 | $0.27 |
| Diluted EPS | $0.26 | -$0.25 | $0.27 | $0.27 |
| Weighted Avg Shares Outstanding | $487.69M | $482.78M | $484.10M | $484.10M |
| Weighted Avg Shares Outstanding (Diluted) | $487.69M | $484.10M | $487.05M | $486.28M |
Over the last four quarters, ALS Limited's revenue moved from $1.08B in Q4 2023 to $1.46B in Q2 2025. Operating income in Q2 2025 was $348.10M, with a strong operating margin of 24%. Despite fluctuations in R&D and SG&A expenses, EBITDA for ALS Limited remained robust at $303.00M, reflecting operational efficiency. Net income rose to $126.80M, with an EPS of $0.26. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan